We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
+2.03%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$6.75B
AUM Growth
+$227M
Cap. Flow
+$450M
Cap. Flow %
6.66%
Top 10 Hldgs %
24.03%
Holding
181
New
21
Increased
67
Reduced
21
Closed
25

Top Buys

Rank Stock Value
1
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
+$76.7M
2
ZYME icon
Zymeworks
ZYME
+$56.8M
3
ENTG icon
Entegris
ENTG
+$55.4M
4
TSM icon
TSMC
TSM
+$52.9M
5
CGEM icon
Cullinan Oncology
CGEM
+$49.2M

Top Sells

Rank Stock Value
1
ECL icon
Ecolab
ECL
+$49.8M
2
W icon
Wayfair
W
+$45.9M
3
EIDX
Eidos Therapeutics, Inc. Common Stock
EIDX
+$41.8M
4
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
+$23.8M
5
CRWD icon
CrowdStrike
CRWD
+$23.5M

Sector Composition

Rank Sector Weight
1 Healthcare 40.16%
2 Technology 26.2%
3 Industrials 11.22%
4 Consumer Discretionary 7.43%
5 Communication Services 4.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CIEN icon
101
Ciena
CIEN
$52.7B
$15.8M 0.23%
288,175
+21,175
+8% +$1.14M
LW icon
102
Lamb Weston
LW
$7.36B
$15.7M 0.23%
203,000
– –
A icon
103
Agilent Technologies
A
$39.2B
$15.7M 0.23%
123,700
+31,200
+34% +$3.86M
FHN icon
104
First Horizon
FHN
$12.1B
$14.7M 0.22%
868,800
+175,100
+25% +$2.77M
PHVS icon
105
Pharvaris
PHVS
$2.37B
$14M 0.21%
+500,000
New +$15.7M
APTO
106
DELISTED
Aptose Biosciences, Inc.
APTO
$13.7M 0.2%
5,109
– –
SHLS icon
107
Shoals Technologies Group
SHLS
$1.49B
$13.7M 0.2%
+392,556
New +$13.9M
PLD icon
108
Prologis
PLD
$136B
$13M 0.19%
123,044
+31,944
+35% +$3.26M
STE icon
109
Steris
STE
$22.5B
$12.9M 0.19%
67,600
+35,950
+114% +$6.67M
BCYC
110
Bicycle Therapeutics
BCYC
$280M
$12.3M 0.18%
+411,838
New +$10.6M
SNV
111
DELISTED
Synovus
SNV
$12.2M 0.18%
+265,900
New +$11.1M
DSGN icon
112
Design Therapeutics
DSGN
$788M
$12M 0.18%
+400,000
New +$13.5M
KLAC icon
113
KLA
KLAC
$236B
$11.8M 0.18%
357,980
+103,000
+40% +$3.1M
PNR icon
114
Pentair
PNR
$10.6B
$11.1M 0.17%
178,700
+78,600
+79% +$4.51M
BOLT icon
115
Bolt Biotherapeutics
BOLT
$7.47M
$10.6M 0.16%
+16,147
New +$10.5M
ORIC icon
116
Oric Pharmaceuticals
ORIC
$1.2B
$10.5M 0.16%
430,000
– –
SGFY
117
DELISTED
Signify Health, Inc.
SGFY
$10.5M 0.16%
+357,360
New +$11.1M
CHMA
118
DELISTED
Chiasma, Inc. Common Stock
CHMA
$9.39M 0.14%
3,000,326
– –
SBNY
119
DELISTED
Signature Bank
SBNY
$8.41M 0.12%
37,200
+11,300
+44% +$2.23M
IEX icon
120
IDEX
IEX
$17.3B
$7.89M 0.12%
37,700
+20,176
+115% +$4M
SNPS icon
121
Synopsys
SNPS
$71.3B
$6.93M 0.1%
27,957
+10,648
+62% +$2.7M
ALXO icon
122
ALX Oncology
ALXO
$262M
$6.64M 0.1%
+90,000
New +$7.08M
VFC icon
123
VF Corp
VFC
$5.87B
$6.52M 0.1%
81,600
+58,000
+246% +$4.71M
AWK icon
124
American Water Works
AWK
$26.7B
$6.46M 0.1%
43,100
+14,200
+49% +$2.15M
FENC icon
125
Fennec Pharmaceuticals
FENC
$344M
$6.46M 0.1%
1,040,000
-80,000
-7% -$602K
3 4
5
6 7

Similar funds

HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return

Eventide Asset Management's Q1 2021 Portfolio in Review

As of Q1 2021, Eventide Asset Management held 181 positions worth $6.75B, up 3.5% from $6.52B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Eventide Asset Management deployed $450M of net new capital in Q1 2021, opening 21 new positions and adding to 67 existing holdings. Its largest new stake was Prometheus Biosciences, Inc. Common Stock: 3,714,032 shares worth $65.6M.

By sector, the portfolio is most concentrated in Healthcare at 40% of assets, down from 42% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Wayfair, an estimated $45.9M trimmed.

  • Eventide Asset Management's largest Q1 2021 buy was Prometheus Biosciences, Inc. Common Stock: 3,714,032 shares worth $65.6M.
  • Eventide Asset Management added most to Entegris in Q1 2021, an estimated $55.4M increase.
  • Eventide Asset Management's biggest Q1 2021 reduction was Wayfair, cutting an estimated $45.9M.
  • Eventide Asset Management fully exited Ecolab in Q1 2021, selling an estimated $49.8M.
  • Eventide Asset Management's ten largest holdings make up 24% of its $6.75B portfolio in Q1 2021.
  • Eventide Asset Management opened 21 new positions and closed 25 in Q1 2021.
  • Eventide Asset Management's portfolio value rose 3.5% quarter-over-quarter to $6.75B.

Based on Eventide Asset Management's 13F filing for Q1 2021, filed 14 May 2021.